ArticleFrontiers in pharmacology2025
Comparative assessment of antibacterial drugs used at the hospital level before and during COVID-19, according to the WHO AWaRe classification.
Article in Frontiers in pharmacology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Antimicrobial Consumption and Prescribing Patterns in Hospitalized Children During and After the COVID-19 Pandemic.Pathogens (Basel, Switzerland) · 2026Article
- SARS-CoV-2 Mpro inhibitors fromFrontiers in chemistry · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Antimicrobial resistance is a major global challenge, and the World Health Organization (WHO) promotes the Access, Watch, and Reserve (AWaRe) classification to support rational antibiotic use. In Kazakhstan, irrational prescribing remains common, and the COVID-19 pandemic intensified the misuse of broad-spectrum antibiotics. A retrospective study at a hospital in Aktobe (2019-2021) analyzed antibiotic use from pharmacy and medical records using the Anatomical Therapeutic Chemical/Defined Daily Dose (ATC/DDD) methodology, with categorization by the WHO AWaRe classification. The analysis revealed a persistent predominance of "Watch" antibiotics, particularly cephalosporins, fluoroquinolones, and carbapenems, with their use intensifying during the COVID-19 pandemic. The share of "Access" antibiotics remained well below the WHO-recommended target of 60%, fluctuating between 24% and 27% across the study period. Reserve antibiotics were not prescribed. The findings reveal gaps in antibiotic stewardship in Kazakhstan: overreliance on "Watch" antibiotics and underuse of "Access" drugs, contrary to WHO guidance. Implementing the AWaRe framework with national targets and monitoring is essential, and the study adds regional evidence to the global AMR discourse, underscoring the need for stronger policies, especially during pandemics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.